Statements (19)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:biotechnology
|
| gptkbp:CEO |
Faheem Hasnain
|
| gptkbp:focus |
immunology
oncology inflammation |
| gptkbp:foundedYear |
2015
|
| gptkbp:founder |
Sheila Gujrathi
Faheem Hasnain |
| gptkbp:headquartersLocation |
gptkb:San_Diego,_California,_United_States
|
| https://www.w3.org/2000/01/rdf-schema#label |
Gossamer Bio
|
| gptkbp:industry |
gptkb:biotechnology
|
| gptkbp:notableProduct |
GB004
seralutinib |
| gptkbp:publiclyTraded |
true
|
| gptkbp:stockExchange |
gptkb:NASDAQ
|
| gptkbp:stockSymbol |
GOSS
|
| gptkbp:website |
https://www.gossamerbio.com/
|
| gptkbp:bfsParent |
gptkb:Sorrento_Mesa
|
| gptkbp:bfsLayer |
8
|